GlaxoSmithKline plc GSK today announced it has extended its tender
offer to acquire all of the outstanding shares of Human Genome Sciences
HGSI for US$13.00 per share in cash to 5:00 p.m. New York City
time on Friday, 29 June 2012. The tender offer was previously scheduled to
expire at 12:00 midnight New York City time, at the end of the day on 7 June
2012.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in